Does RAVULIZUMAB-CWVZ Cause Nasopharyngitis? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Nasopharyngitis have been filed in association with RAVULIZUMAB-CWVZ. This represents 1.9% of all adverse event reports for RAVULIZUMAB-CWVZ.
192
Reports of Nasopharyngitis with RAVULIZUMAB-CWVZ
1.9%
of all RAVULIZUMAB-CWVZ reports
2
Deaths
23
Hospitalizations
How Dangerous Is Nasopharyngitis From RAVULIZUMAB-CWVZ?
Of the 192 reports, 2 (1.0%) resulted in death, 23 (12.0%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Nasopharyngitis Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST